Use of long-acting progesterone to acyclic embryo recipient mares

The objective of this study was to evaluate the efficiency of cyclic and acyclic progesterone-treated recipient mares in a commercial embryo transfer program. Acyclic recipients were treated with decreasing amounts of estradiol cypionate (ECP® - Pfizer Saúde Animal, São Paulo, Brazil), followed by 1...

Full description

Bibliographic Details
Main Authors: Gabriel Maksoud Greco, Fábio Luis Gonçalves Burlamaqui, Aline Emerim Pinna, Fernando José Rohen de Queiroz, Maria Pia dos Santos Cunha, Felipe Zandonadi Brandão
Format: Article
Language:English
Published: Sociedade Brasileira de Zootecnia 2012-03-01
Series:Revista Brasileira de Zootecnia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-35982012000300019
_version_ 1819118137502597120
author Gabriel Maksoud Greco
Fábio Luis Gonçalves Burlamaqui
Aline Emerim Pinna
Fernando José Rohen de Queiroz
Maria Pia dos Santos Cunha
Felipe Zandonadi Brandão
author_facet Gabriel Maksoud Greco
Fábio Luis Gonçalves Burlamaqui
Aline Emerim Pinna
Fernando José Rohen de Queiroz
Maria Pia dos Santos Cunha
Felipe Zandonadi Brandão
author_sort Gabriel Maksoud Greco
collection DOAJ
description The objective of this study was to evaluate the efficiency of cyclic and acyclic progesterone-treated recipient mares in a commercial embryo transfer program. Acyclic recipients were treated with decreasing amounts of estradiol cypionate (ECP® - Pfizer Saúde Animal, São Paulo, Brazil), followed by 1500 mg of a sustained-release progesterone injection (P4LA150® - Laboratórios B.E.T., Rio de Janeiro, Brazil). Out of all 1506 embryo recovery attempts performed, 59.36% were positive (894/1506). Pregnancy rates of cyclic and acyclic mares were, respectively, 44.12% (319/723) and 57.68% (139/241) - higher in acyclic recipients under progesterone treatment. Embryo loss was similar between groups (9.72% 31/319 vs. 11.51% - 16/139). When fertility data on acyclic mares treated with long-action progesterone were grouped in relation to the interval of the beginning of the treatment with progesterone to the embryo transfer, there was no difference in pregnancy rates at 12 days (51.28% - 20/39; 58.92% - 33/56; 60.52% - 46/76 and 58.57% - 41/70 for embryos transferred 3 (P3), 4 (P4), 5 (P5) and 6 (P6) days after the beginning of the treatment with progesterone). Groups P3, P4, P5 and P6 showed embryo loss rates of 20.00% (4/20), 12.12% (4/33), 2.17% (1/46) and 17.07% (7/41), respectively. These rates were similar in groups P3, P4 and P6. Pregnant recipients submitted to an embryo transferring procedure on P5 showed lower embryo mortality rates than on P3 and P6. P4 recipients tended to suffer higher embryo mortality rates than P5. Acyclic recipient mares under progesterone treatment can be satisfactoryly used in embryo transfer programs.
first_indexed 2024-12-22T05:44:06Z
format Article
id doaj.art-b519d09cd2504139a15b0d227d2b53f9
institution Directory Open Access Journal
issn 1516-3598
1806-9290
language English
last_indexed 2024-12-22T05:44:06Z
publishDate 2012-03-01
publisher Sociedade Brasileira de Zootecnia
record_format Article
series Revista Brasileira de Zootecnia
spelling doaj.art-b519d09cd2504139a15b0d227d2b53f92022-12-21T18:37:06ZengSociedade Brasileira de ZootecniaRevista Brasileira de Zootecnia1516-35981806-92902012-03-0141360761110.1590/S1516-35982012000300019Use of long-acting progesterone to acyclic embryo recipient maresGabriel Maksoud GrecoFábio Luis Gonçalves BurlamaquiAline Emerim PinnaFernando José Rohen de QueirozMaria Pia dos Santos CunhaFelipe Zandonadi BrandãoThe objective of this study was to evaluate the efficiency of cyclic and acyclic progesterone-treated recipient mares in a commercial embryo transfer program. Acyclic recipients were treated with decreasing amounts of estradiol cypionate (ECP® - Pfizer Saúde Animal, São Paulo, Brazil), followed by 1500 mg of a sustained-release progesterone injection (P4LA150® - Laboratórios B.E.T., Rio de Janeiro, Brazil). Out of all 1506 embryo recovery attempts performed, 59.36% were positive (894/1506). Pregnancy rates of cyclic and acyclic mares were, respectively, 44.12% (319/723) and 57.68% (139/241) - higher in acyclic recipients under progesterone treatment. Embryo loss was similar between groups (9.72% 31/319 vs. 11.51% - 16/139). When fertility data on acyclic mares treated with long-action progesterone were grouped in relation to the interval of the beginning of the treatment with progesterone to the embryo transfer, there was no difference in pregnancy rates at 12 days (51.28% - 20/39; 58.92% - 33/56; 60.52% - 46/76 and 58.57% - 41/70 for embryos transferred 3 (P3), 4 (P4), 5 (P5) and 6 (P6) days after the beginning of the treatment with progesterone). Groups P3, P4, P5 and P6 showed embryo loss rates of 20.00% (4/20), 12.12% (4/33), 2.17% (1/46) and 17.07% (7/41), respectively. These rates were similar in groups P3, P4 and P6. Pregnant recipients submitted to an embryo transferring procedure on P5 showed lower embryo mortality rates than on P3 and P6. P4 recipients tended to suffer higher embryo mortality rates than P5. Acyclic recipient mares under progesterone treatment can be satisfactoryly used in embryo transfer programs.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-35982012000300019embryo lossembryo transfermarepregnancy
spellingShingle Gabriel Maksoud Greco
Fábio Luis Gonçalves Burlamaqui
Aline Emerim Pinna
Fernando José Rohen de Queiroz
Maria Pia dos Santos Cunha
Felipe Zandonadi Brandão
Use of long-acting progesterone to acyclic embryo recipient mares
Revista Brasileira de Zootecnia
embryo loss
embryo transfer
mare
pregnancy
title Use of long-acting progesterone to acyclic embryo recipient mares
title_full Use of long-acting progesterone to acyclic embryo recipient mares
title_fullStr Use of long-acting progesterone to acyclic embryo recipient mares
title_full_unstemmed Use of long-acting progesterone to acyclic embryo recipient mares
title_short Use of long-acting progesterone to acyclic embryo recipient mares
title_sort use of long acting progesterone to acyclic embryo recipient mares
topic embryo loss
embryo transfer
mare
pregnancy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-35982012000300019
work_keys_str_mv AT gabrielmaksoudgreco useoflongactingprogesteronetoacyclicembryorecipientmares
AT fabioluisgoncalvesburlamaqui useoflongactingprogesteronetoacyclicembryorecipientmares
AT alineemerimpinna useoflongactingprogesteronetoacyclicembryorecipientmares
AT fernandojoserohendequeiroz useoflongactingprogesteronetoacyclicembryorecipientmares
AT mariapiadossantoscunha useoflongactingprogesteronetoacyclicembryorecipientmares
AT felipezandonadibrandao useoflongactingprogesteronetoacyclicembryorecipientmares